Literature DB >> 7775935

Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China.

R R Wu1, M Mizokami, J Y Lau, T Ohno, Z X Fang, K Ohba, X S Wu, A Hata, M Sasaki, S Iino.   

Abstract

The seroprevalence of hepatitis C virus (HCV) infection in Lanzhou, Western China was studied. HCV genotypes in 20 patients with HCV infection was determined by genotype-specific primer for polymerase chain reaction (PCR) based on HCV core region and compared with the genotype assigned by sequence comparison and molecular evolutionary analysis based on the same region. Antibody to HCV (anti-HCV) was present in 2.5% of volunteer blood donors and in 35.0% of paid blood donors (P < 0.01). HCV infection is uncommon in patients with liver disease who attended liver clinics in this locality; 4.0% with acute hepatitis and 4.0% with chronic hepatitis, 10.0% with liver cirrhosis, and none with hepatocellular carcinoma were seropositive for anti-HCV. Genotype 1b and 2a were both found to be prevalent. Together, they accounted for 19 of 20 (95%) patients with HCV infection. Sequencing of the HCV core region from two patients showed that the assignment of HCV genotype by genotype-specific primers for PCR matched well with the genotyping results based on sequence comparison and molecular evolutionary analysis. These data showed that HCV is present in Western China, HCV infection is more common in paid blood donors, and HCV genotypes 1b and 2a are both prevalent in Western China.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775935     DOI: 10.1002/jmv.1890450211

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Prevalence of hepatitis C virus infection in Nanjing, southern China.

Authors:  K Suzuki; M Mizokami; K Cao; X S Wu; R R Wu; A Hata; M Sasaki; Z X Fang; L Y Zhang; J Y Lau; S Iino
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

Review 2.  Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors:  Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal:  J Epidemiol       Date:  2011-10-22       Impact factor: 3.211

3.  Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011.

Authors:  Xia Rong; Ru Xu; Huaping Xiong; Min Wang; Ke Huang; Qiuyu Chen; Chengyao Li; Qiao Liao; Jieting Huang; Wenjie Xia; Guangping Luo; Xin Ye; Ming Zhang; Yongshui Fu
Journal:  Arch Virol       Date:  2014-08-02       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.